Tanja Gonska
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (5)
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Highly effective drugs modulating the defective protein encoded by the CFTR gene have revolutionized cystic fibrosis (CF) therapy. Preclinical drug-testing on human nasal epithelial (HNE) cell cultures and 3-dimensional human intestinal organoids (3D HIO) are used to address patient-specific variation in drug response and to optimize individual treatment for people with CF. This study is the first to report comparable CFTR functional responses to CFTR modulator treatment among patients with different classes of CFTR gene variants using the three methods of 2D HIO, 3D HIO, and HNE. Furthermore, 2D HIO showed good correlation to clinical outcome markers. A larger measurable CFTR functional range and access to the apical membrane were identified as advantages of 2D HIO over HNE and 3D HIO, respectively. Our study thus expands the utility of 2D intestinal monolayers as a preclinical drug testing tool for CF.
Year:
2023
Collaborators (6)
Chee Ooi
University of New South Wales
Bernadette Prentice
New South Wales Department of Planning and Environment
Bowen Li
Associate Professor
University of Toronto
Yue Xu
Assistant Professor
University of Toronto
Jim Hu
Professor
University of Toronto
Haissi Cui
Assistant Professor
University of Toronto
Make your next move.
Prepare your application
Review drafts before you send them.